Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmes

Booy, 1994, Efficacy ofHaemophilus influenzae type b conjugate vaccine PRP‐T, Lancet, 344, 362, 10.1016/S0140-6736(94)91400-1 Eskola, 1987, Secondary cases of invasive disease caused by spread ofHaemophilus influenzae type b, J Infect, 14, 233, 10.1016/S0163-4453(87)93460-8 Black, 1991, Efficacy in infancy of oligosaccharide conjugateHaemophilus influenzae type b (HbOC) vaccine in a United States population of 61,080 children. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group, Pediatr Infect Dis J, 10, 97, 10.1097/00006454-199102000-00004 Santosham, 1991, The efficacy in Navajo infants of a conjugate vaccine consisting ofHaemophilus influenzae type b polysaccharide andNeisseria meningitidis outer‐membrane protein complex, N Engl J Med, 324, 1767, 10.1056/NEJM199106203242503 Ramsay, 2003, EstimatingHaemophilus influenzae type b vaccine effectiveness in England and Wales by use of the screening method, J Infect Dis, 188, 481, 10.1086/376997 Heath, 2000, Antibody concentration and clinical protection after Hib conjugate vaccination in the United Kingdom, JAMA, 284, 2334, 10.1001/jama.284.18.2334 Heath, 2002, The UK Hib vaccine experience, Arch Dis Child, 86, 396, 10.1136/adc.86.6.396 Fogarty, 1995, The epidemiology ofHaemophilus influenzae type b disease in the Republic of Ireland, Epidemiol Infect, 114, 451, 10.1017/S095026880005216X Herceg, 1997, The decline ofHaemophilus influenzae type b disease in Australia, Commun Dis Intell, 21, 173 Hargreaves, 1996, Changing patterns of invasiveHaemophilus influenzae disease in England and Wales after introduction of the Hib vaccination programme, BMJ, 312, 160, 10.1136/bmj.312.7024.160 Garpenholt, 1996, The impact ofHaemophilus influenzae type b vaccination in Sweden, Scand J Infect Dis, 28, 165, 10.3109/00365549609049069 Heath, 2000, Clinical and immunological risk factors associated withHaemophilus influenzae type b conjugate vaccine failure in childhood, Clin Infect Dis, 31, 973, 10.1086/318132 Holmes, 1991, Immunoglobulin deficiency and idiotype expression in children developingHaemophilus influenzae type b disease after vaccination with conjugate vaccine. The Collaborative Study Group, JAMA, 266, 1960, 10.1001/jama.1991.03470140072027 Holmes, 1992, The biology ofHaemophilus influenzae type b vaccination failure, J Infect Dis, 165, S121, 10.1093/infdis/165-Supplement_1-S121 Breukels, 2001, Immunological characterization of conjugatedHaemophilus influenzae type b vaccine failure in infants, Clin Infect Dis, 32, 1700, 10.1086/320755 Phipps, 1990, An ELISA employing aHaemophilus influenzae type b oligosaccharide‐human serum albumin conjugate correlates with the radioantigen binding assay, J Immunol Methods, 135, 121, 10.1016/0022-1759(90)90264-V Madore, 1996, Interlaboratory study evaluating quantitation of antibodies toHaemophilus influenzae type b polysaccharide by enzyme‐linked immunosorbent assay, Clin Diagn Lab Immunol, 3, 84, 10.1128/CDLI.3.1.84-88.1996 Lee, 2008, Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high‐quality antibody, Clin Infect Dis, 46, 186, 10.1086/524668 Milford‐Ward, 1996 Hugosson, 1995, InvasiveHaemophilus influenzae disease: epidemiology and clinical spectrum before large‐scale H. influenzae type b vaccination, Scand J Infect Dis, 27, 63, 10.3109/00365549509018974 Gervaix, 1991, Epidemiology of invasiveHaemophilus influenzae type b infections in Geneva, Switzerland, 1976 to 1989, Pediatr Infect Dis J, 10, 370, 10.1097/00006454-199105000-00005 Takala, 1989, Epidemiology of invasiveHaemophilus influenzae type b disease among children in Finland before vaccination withHaemophilus influenzae type b conjugate vaccine, Pediatr Infect Dis J, 8, 297 Booy, 1993, InvasiveHaemophilus influenzae type b disease in the Oxford region (1985–91), Arch Dis Child, 69, 225, 10.1136/adc.69.2.225 McGregor, 1992, InvasiveHaemophilus influenzae infection in the Australian Capital Territory region, Med J Aust, 156, 569, 10.5694/j.1326-5377.1992.tb121421.x Eskola, 1996, Ten years’ experience withHaemophilus influenzae type (Hib) conjugate vaccines in Finland, Rev Med Microbiol, 7, 231, 10.1097/00013542-199610000-00005 Kristensen, 1990, Carriage and antibiotic susceptibility ofHaemophilus influenzae type b and non b in Danish day‐care attendees, APMIS, 98, 50, 10.1111/j.1699-0463.1990.tb01001.x Hanna, 1990, The epidemiology of invasiveHaemophilus influenzae infections in children under five years of age in the Northern Territory: a three‐year study, Med J Aust, 152, 234, 10.5694/j.1326-5377.1990.tb120916.x Reinert, 1993, Epidemiology ofHaemophilus influenzae type b disease in France, Vaccine, 11, S38, 10.1016/0264-410X(93)90158-T van Alphen, 1997, Effect of nationwide vaccination of 3‐month‐old infants in The Netherlands with conjugateHaemophilus influenzae type b vaccine: high efficacy and lack of herd immunity, J Pediatr, 131, 869, 10.1016/S0022-3476(97)70035-0 McIntyre, 1991, InvasiveHaemophilus influenzae type b disease in Sydney children 1985–1987: a population‐based study, Med J Aust, 154, 832, 10.5694/j.1326-5377.1991.tb121377.x Ladhani, 2009, Recommendations for the prevention of secondaryHaemophilus influenzae type b (Hib) disease, J Infect, 58, 3, 10.1016/j.jinf.2008.10.007 Johnson, 1996, Differing antibody responses toHaemophilus influenzae type b after meningitis or epiglottitis, Epidemiol Infect, 116, 21, 10.1017/S095026880005891X Auckland, 2006, Clinical and immunologic risk factors for meningococcal C conjugate vaccine failure in the United Kingdom, J Infect Dis, 194, 1745, 10.1086/509619 Cates, 1987, Second episodes ofHaemophilus influenzae type b disease following rifampin prophylaxis of the index patients, Pediatr Infect Dis J, 6, 512, 10.1097/00006454-198706000-00004 Heath, 2003, Hib vaccination in infants born prematurely, Arch Dis Child, 88, 206, 10.1136/adc.88.3.206 Omenaca, 2005, Response of preterm newborns to immunization with a hexavalent diphtheria‐tetanus‐acellular pertussis‐hepatitis B virus‐inactivated polio andHaemophilus influenzae type b vaccine: first experiences and solutions to a serious and sensitive issue, Pediatrics, 116, 1292, 10.1542/peds.2004-2336 Costa‐Carvalho, 2006, Antibody response to pneumococcal capsular polysaccharide vaccine in Down syndrome patients, Braz J Med Biol Res, 39, 1587, 10.1590/S0100-879X2006001200010 Avanzini, 1988, IgG subclass deficiency in patients with Down’s syndrome and aberrant hepatitis B vaccine response, Scand J Immunol, 28, 465, 10.1111/j.1365-3083.1988.tb01477.x Department of Health. NHS Maternity Statistics, England: 1998–99 to 2000–01. Crown Copyright, 2002. Available at http://www.dh.gov.uk/en/Publicationsandstatistics/Statistics/StatisticalWorkAreas/Statisticalhealthcare/DH_4086519 (last accessed 1 May 2009). Ladhani, 2008, Fall inHaemophilus influenzae serotype b (Hib) disease following implementation of a booster campaign, Arch Dis Child, 93, 665, 10.1136/adc.2007.126888 Fitzgerald, 2007, InvasiveHaemophilus influenzae type b disease in Ireland, 2006/7, EPI-Insight, 8, 4